{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreigoqqy7rrgcfabyqxel6qxxct6wjpkqx4fl2zcj2bikatrnamzk6m",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mgcvosp2exw2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreibnijrthqtup4vobt5igeroykne5l452bkeui4cvzb3rluhjc2d4q"
    },
    "mimeType": "image/jpeg",
    "size": 223106
  },
  "path": "/news/2026-03-molecular-immunogenicity-cancer-immunotherapy.html",
  "publishedAt": "2026-03-05T07:10:07.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Researchers at the National University of Singapore (NUS) have identified a protein called tyrosine phosphatase 1B (PTP1B) as a potential \"switch\" that can modulate a type of cancer cell death known as immunogenic cell death (ICD).",
  "title": "Molecular target drives immunogenicity in cancer immunotherapy"
}